In this dataset, the frequency of HLA-DRB1*15:01 was significantly higher in MS participants compared to healthy controls, as expected (44.76% vs. 21.71%, p = 2.491e-06). This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.